Home » Product Liability » Risperdal


Risperdal (brand name risperidone) is a Federal Drug Administration-approved antipsychotic drug for treatment of several psychiatric and related conditions. It is manufactured by Johnson & Johnson and used to treat a variety of psych-disorders, including:

  • Schizophrenia
  • Schizophrenia in children age 13-17. It is the only drug approved for this mental illness in this age group.
  • Bipolar disorder in children age 10-17
  • Irritability in minors with autism

Serious Problems Associated With Risperdal?

Risperdal has been linked to a host of severe health dangers. Clinical evidence shows a connection between Risperdal and gynecomastia, or the enlargement of breasts in boys. The 2006 Duke University study that found this side effect also found that girls on the drug produced breast milk before even reaching puberty. A study co-author said hormonal changes causing these abnormalities could be hazardous and several doctors told the FDA in 2008 that they were concerned about children taking the drug. Nonetheless, the agency refused to strengthen warnings about Risperdal.

Severe trouble with the drug has been found at the other end of the age spectrum as well. Risperdal is also used to treat aggression and psychosis in dementia patients — an “unapproved” use — the FDA requires Johnson & Johnson to place a black box warning on the drug — the most severe warning a drug can carry. The warning specifically states that elderly dementia patients taking Risperdal are more likely to die.

Other studies have associated Risperdal with an increased risk of Type II diabetes, especially in children. In 2003, the FDA suggested Johnson & Johnson sell Risperdal with a label warning patients of this risk, which it did, but regulators still found the company downplayed the greater dangers patients faced of diabetes and stroke.

Patients on Risperdal can also develop neuroleptic malignant syndrome, a potentially fatal reaction to the drug. Other symptoms of neuroleptic malignant syndrome are:

  • Coma
  • Delirium
  • Elevated white blood cell count
  • Muscle tissue destruction

Successful Litigation Over Risperdal

Action against Johnson & Johnson over the use of Risperdal in children has found its way to the legal system, with highly unfavorable results for the company. Outcomes have included:

$2.2 Billion

In 2013, Johnson & Johnson agreed to pay $2.2 billion to settle various federal allegations, including advertising Risperdal for unapproved uses, such as the treatment of vulnerable elderly dementia patients.

$181 Million

In 2012, a $181 million consumer fraud settlement with 36 states and the District of Columbia over allegations the drug maker promoted the drug for unapproved uses.

$327 Million

In 2011, a $327 million fine by South Carolina for exaggerating the effectiveness of the drug.

Undisclosed Settlement

2011: Just as a Risperdal gynecomastia lawsuit was about to go to trial, Johnson & Johnson announced a settlement with the plaintiff, who said he grew breasts when he was 9. The amount was undisclosed.

What Should You Do?

If you or someone you know on Risperdal has died or suffered from gynecomastia, diabetes, tardive dyskinesia or other known symptoms, you should immediately contact the attorneys at Hodes Milman, LLP to find out about your rights. It is important your matter is immediately investigated.

We are experienced defective product trial lawyers dedicated to helping people recover money when they have been harmed by dangerous drugs, medical malpractice, catastrophic injury and wrongful death.

Experience You Can Trust

For more than 30 years, Hodes Milman has provided families and individuals experienced, trusted and compassionate legal representation when they've been injured by another's carelessness or negligence. As a team of personal injury and product liability attorneys, Hodes Milman provides focused expertise to build a strategic case against negligent, injurious and willful offenders.

Featured in the News

For their support of the Veterans Legal Institute, Managing Partners Jeff Milman and Dan Hodes received special recognition from the State of California, Congress and the United States. The firm has fought relentlessly to protect those who have served the country in matters involving medical malpractice, medical negligence and federal... Read More

Local Charities
Volunteer Work
Speaking and Press